A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Background: Two new formulations of an investigational 15-valent pneumococcal conjugate vaccine (PCV15-A and PCV15-B) were developed using 2 different protein-polysaccharide conjugation processes and evaluated in separate phase I/II studies (NCT02037984 [V114-004] and NCT02531373 [V114-005]) to asse...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Rupp, R., Hurley, D., Grayson, S., Li, J., Nolan, K., McFetridge, R.D., Hartzel, J., Abeygunawardana, C., Winters, M., Pujar, H., Benner, P., Musey, L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2019
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988874/
https://ncbi.nlm.nih.gov/pubmed/30689507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1568159
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia